Companies/Covalon Technologies Ltd.

Company profile

Covalon Technologies Ltd.

OTC: CVALF · Healthcare · Biotechnology

Canadian filerHQ Mississauga, ONReports USD

#526 of 1,394 Healthcare companies by revenue46th-percentile growth

EA Score

78B+

FH 85DQ —GM 62SS 65

v0.1 · 45/100 weight · provisional

↑ return on assets, Altman-Z · ↓ revenue growth (YoY), disclosure history

Methodology →

Revenue TTM

$23.7M

Rev growth YoY (TTM)

-2.9%

Net income (FY)

$1.5M

Employees

105

Market cap

$40.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$23.5M32.8M CAD2025

Net income$1.5M2.1M CAD2025

Operating income$1.3M1.8M CAD2025

Total assets$25.9M36.1M CAD2025

Liabilities$3.9M5.4M CAD2025

Equity$22.1M30.7M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$20.8M

FY18

$25.6M

FY19

$19.2M

FY20

$15.5M

FY21

$14.2M

FY22

$19.7M

FY23

$22.9M

FY24

$23.5M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Covalon Technologies Ltd. booked $23.5M in FY2025 revenue, growing 2.4% year over year — about the middle of the pack among Healthcare companies we track, at a 6.3% net margin.

Peers · Healthcare

Park Dental Partners, Inc. Common Stock——Gossamer Bio, Inc.24D Star Equity Holdings, Inc.60C Elutia Inc52D

Key facts

CEOBrent Ashton

SectorHealthcare

IndustryBiotechnology

HeadquartersMississauga, ON

ExchangeOTC: CVALF

Employees105

IPO date2007-04-18

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.